Authors: DEMARCHI S CECCHIN E FALLETI E GIACOMELLO R STEL G SEPIACCI G BORTOLOTTI N ZANELLO F GONANO F BARTOLI E

Citation: S. Demarchi et al., LONG-TERM EFFECTS OF ERYTHROPOIETIN THERAPY ON FISTULA STENOSIS AND PLASMA-CONCENTRATIONS OF PDGF AND MCP-1 IN HEMODIALYSIS-PATIENTS, Journal of the American Society of Nephrology, 8(7), 1997, pp. 1147-1156

Authors: DEMARCHI S FALLETI E GIACOMELLO R STEL G CECCHIN E SEPIACCI G BORTOLOTTI N ZANELLO F GONANO F BARTOLI E

Citation: S. Demarchi et al., RISK-FACTORS FOR VASCULAR-DISEASE AND ARTERIOVENOUS-FISTULA DYSFUNCTION IN HEMODIALYSIS-PATIENTS, Journal of the American Society of Nephrology, 7(8), 1996, pp. 1169-1177

Authors: DEMARCHI S CECCHIN E SEPIACCI G VILLALTA D SANTINI G BARTOLI E

Citation: S. Demarchi et al., EFFECTS OF ERYTHROPOIETIN ON SPONTANEOUS HISTAMINE-RELEASE IN WHOLE-BLOOD IN HEMODIALYSIS-PATIENTS, Kidney international, 44(6), 1993, pp. 1394-1394

Authors: DEMARCHI S CECCHIN E VILLALTA D SEPIACCI G SANTINI G BARTOLI E

Citation: S. Demarchi et al., RELIEF OF PRURITUS AND DECREASES IN PLASMA HISTAMINE CONCENTRATIONS DURING ERYTHROPOIETIN THERAPY IN PATIENTS WITH UREMIA, The New England journal of medicine, 326(15), 1992, pp. 969-974